Literature DB >> 27343304

Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.

M Hellard1,2,3, R Sacks-Davis1,4, J Doyle1,2,4.   

Abstract

Keywords:  ACCESS TO HLTH CARE; COMMUNICABLE DISEASES; EPIDEMIOLOGY; HEPATITIS; PREVENTION

Year:  2016        PMID： 27343304     DOI： 10.1136/jech-2015-205454

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  10 in total

1.  Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.

Authors:  Mary M Ford; Payal S Desai; Gil Maduro; Fabienne Laraque
Journal:  J Urban Health       Date:  2017-10       Impact factor: 3.671

2.  Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.

Authors:  Barrot H Lambdin; Jennifer Lorvick; Jessie K Mbwambo; John Rwegasha; Saria Hassan; Paula Lum; Alex H Kral
Journal:  Int J Drug Policy       Date:  2017-06-17

3.  Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.

Authors:  Chung-Feng Huang; Etsuko Iio; Dae Won Jun; Eiichi Ogawa; Hidenori Toyoda; Yao-Chun Hsu; Hiroaki Haga; Shinji Iwane; Masaru Enomoto; Dong Hyun Lee; Grace Wong; Chen-Hua Liu; Toshifumi Tada; Wan-Long Chuang; Ramsey Cheung; Jun Hayashi; Cheng-Hao Tseng; Satoshi Yasuda; Sally Tran; Leslie Kam; Linda Henry; Jae Yoon Jeong; Hideyuki Nomura; Seung Ha Park; Makoto Nakamuta; Jee-Fu Huang; Chi-Ming Tai; Gin-Ho Lo; Mei-Hsuan Lee; Hwai-I Yang; Jia-Horng Kao; Akihiro Tamori; Yuichiro Eguchi; Yoshiyuki Ueno; Norihiro Furusyo; Yasuhito Tanaka; Ming-Lung Yu; Mindie H Nguyen
Journal:  Hepatol Int       Date:  2019-08-28       Impact factor: 9.029

4.  A Systems Thinking Approach to Understanding and Demonstrating the Role of Peer-Led Programs and Leadership in the Response to HIV and Hepatitis C: Findings From the W3 Project.

Authors:  Graham Brown; Daniel Reeders; Aaron Cogle; Annie Madden; Jules Kim; Darryl O'Donnell
Journal:  Front Public Health       Date:  2018-08-31

5.  Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain.

Authors:  Regina Juanbeltz; Alejandra Pérez-García; Aitziber Aguinaga; Iván Martínez-Baz; Itziar Casado; Cristina Burgui; Silvia Goñi-Esarte; Jesús Repáraz; José Manuel Zozaya; Ramón San Miguel; Carmen Ezpeleta; Jesús Castilla
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

6.  Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives.

Authors:  Jorge Mera; Kartik Joshi; Karla Thornton; Terry Box; John Scott; Miranda Sedillo; Paulina Deming; Crystal David; Whitney Essex; Richard Manch; Anita Kohli
Journal:  Open Forum Infect Dis       Date:  2019-07-04       Impact factor: 3.835

Review 7.  Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.

Authors:  Soo-Kyung Park; Chang Hwan Choi; Jaeyoung Chun; Heeyoung Lee; Eun Sun Kim; Jae Jun Park; Chan Hyuk Park; Bo-In Lee; Yunho Jung; Dong-Il Park; Do Young Kim; Hana Park; Yoon Tae Jeen
Journal:  Intest Res       Date:  2020-01-30

8.  Medical injection and access to sterile injection equipment in low- and middle-income countries: a meta-analysis of Demographic and Health Surveys (2010-2017).

Authors:  Emmanuel O Adewuyi; Asa Auta
Journal:  Int Health       Date:  2020-09-01       Impact factor: 2.473

9.  Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia.

Authors:  Anneli Uusküla; Ave Talu; Jürgen Rannap; David M Barnes; Don Des Jarlais
Journal:  Harm Reduct J       Date:  2021-04-01

10.  Cost-effectiveness of treating hepatitis C in Seychelles.

Authors:  Naomi Joan Faray Adeline; Claudia Geue; Mohsen Rezaei Hermami
Journal:  Pan Afr Med J       Date:  2019-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.